Genentech to Begin Clinical Trial of Drug Treatment for COVID-19

Name: Genentech to Begin Clinical Trial of Drug Treatment for COVID-19
Uploaded: 2020-03-28T02:48:14+00:00
Duration: P114S
Description: KPIX 5 spoke to Dr. Levi Garraway, chief medical officer at Genentech, about a pending clinical trial of Actemra, an anti-inflammatory medicine, as a possible

Video Credit: CBS 5 SF KPIX - Duration: 01:54s - Published on March 28, 2020

Genentech to Begin Clinical Trial of Drug Treatment for COVID-19

KPIX 5 spoke to Dr. Levi Garraway, chief medical officer at Genentech, about a pending clinical trial of Actemra, an anti-inflammatory medicine, as a possible treatment for COVID-19 patients.

(3-27-20)

0 shares	Share Tweet Save Post Send

Related videos from verified sources

UC Davis Medical Center Joins Coronavirus Treatment Clinical Trial [Video]

UC Davis Medical Center Joins Coronavirus Treatment Clinical Trial

The medical center is working with the federal government to find out if an experimental drug can help treat the virus.

Credit: CBS 13 Sacramento Duration: 00:22Published on March 24, 2020

N.Y. To Start Clinical Drug Trial On Coronavirus Treatment [Video]

N.Y. To Start Clinical Drug Trial On Coronavirus Treatment

New York state is expected to start trials on a drug to possibly treat coronavirus on Tuesday, Gov. Cuomo announced on Sunday. CBS2's Dana Tyler reports

Credit: CBS 2 New York Duration: 00:28Published on March 23, 2020

Antiviral Trial: HIV Drug Failed To Help COVID-19 Patients [Video]

Antiviral Trial: HIV Drug Failed To Help COVID-19 Patients

Some of the first clinical data for a potential coronavirus treatment showed it did not help.

Credit: Rumble Duration: 00:32Published on March 19, 2020

Genentech to Begin Clinical Trial of Drug Treatment for COVID-19

You Might Like

Related videos from verified sources